B & B Pharmaceuticals, Inc.
B & B Pharmaceuticals, Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 4 FDA inspections, and 1 compliance action on record. Its most recent recall (D-1244-2020, Class II) was initiated on April 14, 2020.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 4
- Compliance Actions
- 1
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1244-2020 | Class II | Estradiol, USP (Non-Micronized) (Hemihydrate), packaged in: a) 500 grams (NDC 63275-9900-8), b) 100 | April 14, 2020 |